Skip to main content
. 2004 May 25;90(12):2288–2296. doi: 10.1038/sj.bjc.6601810

Table 5. Analgesic drugs assumed by the 1021 patients during the first 3 weeks.

ATC categories n° (%) of patients
M01A anti-inflammatory products, nonsteroids 140 (14%)
 M01AB acetic acid derivatives (e.g.diclofenac, ketorolac) 107 (10%)
 M01AC oxicam (e.g. piroxicam) 4 (<1%)
 M01AE propionic acid derivatives (e.g. ibuprofen, naproxen) 15 (1%)
 M01AX other anti-inflammatory, nonsteroids (e.g. nimesulide) 18 (2%)
   
N02 analgesics 167 (16%)
N02A opioids 72 (7%)
  N02AA morphine 26 (3%)
  N02AB fentanyl 7 (1%)
  N02AC dextropropoxyphene 1 (<1%)
  N02AE buprenorphine 7 (1%)
  N02AX tramadol 32 (3%)
   
N02B other analgesics and antipyretics 97 (9%)
  N02BA salicylic acid and derivatives 3 (<1%)
  N02BE anilides (e.g. acetaminophen) 23 (2%)
   
N02BE in association with opioids (codeine+acetaminophen) 71 (7%)